 Today, I have the privilege of speaking with Mike Druhan from Medics Health Today. How are you? I'm great, Trace. And of course, Mike, you literally have breaking news. So congratulations. This, to me, is big news. Let's start there. Tell our audience what this news is, please. So Health Partners UK is in the occupation of health services business. It's a really big vertical market. Okay. So they have over 2 million captive patients within their roster. The due diligence they did on us was about a six month technical due diligence to make sure that when we keep saying our system is scalable and secure, that goes with a just an easy statement, but an awful lot of due diligence behind that to make sure because of course, we're carrying and handling their health patients information. So going through this first announcement we did today, if you read carefully the announcement, we're doing a pilot. All our pilots are paid for. It'll run six months. They'll put six under their patients through. It's really to get an idea of the throughput, making sure the customer getting everything ready. Then we'll move to a commercial arrangement from there. If we get through, and we believe in all instances, we'll get through that successfully, that opens us up to their two million patients. This will take a while to roll through this, but they have 76 stationary clinics that service those two million patients. And they have 31 mobile clinics that we will have the opportunity to participate with our technology in so we can reach out to their patients. It's a really big deal. And if you look at the, sorry, one more statement, if you look at the cancer statistics in the UK, 3,000 people that are in the outdoors world of their head skin cancer last year, according to the health and safety. This gives us an opportunity to go in there and do what we do best. Keep employees working and healthy and being able to catch melanomas early rather than later when they become a lot more deadly and a lot more lethal. Well, it sounds like a large opportunity, but it also sounds like it's kind of a negative too. Out of 600 people, the percentage is higher than we may want to believe. While this will be a positive for your shareholders, tell us how that could be a positive. I'm assuming early detection. Yes, Mike? That's 100%. If we catch a worker that's outside and a lot of the workers that are working with health partners are outside workers, seasonal and outside workers, if you catch a melanoma at a stage one, the life expectancy is 99%. They're going to be fine. We can get it taken out. They're great. The cost to the overall insurer is only a few thousand dollars. That patient left alone untreated, gets to a stage four melanoma. Those costs go up to a million dollars to keep that patient alive for about a 30% chance of them being around after five years. It's just devastating. They lose family. They're not working. So let's catch it early. Based on what you're telling me as well, Mike, there would also be another win-win for medics health. You're basically proving that one of the largest health providers in Europe, out of all your competitors, has selected you to be their partner and work with you. Yeah, that's a big statement. There's nobody that I'm aware of in the industry that can do telodermatology on the scale and the safety and the security that we can. This is a big, big feather in our cap for that. And also, it allows us to expand that into other markets that there are the identical replicable markets that our partners at Health Partners aren't in around the world because we have a good understanding of what the drivers are in that market. And of course, there's a lot of occupational health suppliers out there that will see this announcement that will give us ease of access to that location too. Well, we support you in your fight against skin cancer, Mike. We continue to be amazed at the difference in early detection and how it can enhance people's lives. So, Mike and medics health team, keep up the amazing work. Thank you for this great update. Thanks so much, Tracy. Take care.